How to read cellular therapy reviews without being sold

Look for details you can check

Useful comments say what happened. They may mention whether calls were returned, costs were clear, or follow-up arrived when promised.

Vague praise won't tell you much. Neither will a complaint that leaves out what went wrong or how the office responded.

Read several comments before you form an opinion. Repeated details are more useful than one dramatic account, though they still aren't proof.

Ask what happened before and after care

A good result may sound convincing, but the review may skip key facts. You won't know the person's exam, other care, daily activity, or health.

Ask the office how it decides who may be helped. The licensed clinic staff need to examine and treat you based on your own joint.

Find out how progress is checked after care. If the answer is only that people feel better, ask for a clearer way to judge.

Bring the same questions to every call

Ask who does the exam and what medical papers are needed. Then ask about the full cost, the likely time involved, and help after the visit.

Don't forget other choices. The office should explain what may help at home, what a regular doctor can do, and when surgery might be discussed.

Take useful notes while the answers are fresh. You'll compare clinics more fairly and notice when a clear answer never came.

Take time to think after the call. You don't need to decide while someone is still talking.

Evidence sources

1. In a 480-patient, four-arm, multicenter randomized phase 2/3 trial, none of three orthobiologic cell injections - autologous bone marrow aspirate concentrate, autologous adipose stromal vascular fraction, or allogeneic umbilical cord tissue-derived mesenchymal stromal cells - was superior to any other, or to a corticosteroid injection control, on pain at 12 months.

   Mautner K, et al. — Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial. Nat Med, 2023.

2. A 2025 systematic review and meta-analysis of 8 randomized trials in 502 patients found intra-articular mesenchymal stem cells improved WOMAC scores versus control at 6 months (MD 7.44, 95% CI 1.45-13.42) and 12 months (MD 10.31, 95% CI 0.96-19.67), with wide confidence intervals and a small pooled sample.

   Cao M, et al. — Efficacy and safety of mesenchymal stem cells in knee osteoarthritis: a systematic review and meta-analysis of randomized controlled trials. Stem Cell Res Ther, 2025.